Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$15.71
+4.0%
$14.85
$8.26
$19.41
$1.35B-0.011.31 million shs521,610 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$3.36
+5.5%
$2.99
$2.50
$9.37
$133.66M0.45313,921 shs37,809 shs
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$3.50
+2.0%
$3.80
$2.03
$8.45
$179.92M2.47206,173 shs4,197 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$9.94
+2.9%
$10.01
$8.61
$21.10
$231.36M0.95250,186 shs31,588 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
+3.85%+4.28%+14.65%+11.93%+36.28%
Pulmonx Corporation stock logo
LUNG
Pulmonx
+0.95%+18.66%+21.37%-33.19%-59.85%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-2.00%-7.30%-15.52%+14.72%-54.93%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.47%-3.78%-3.11%-30.00%-21.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.2551 of 5 stars
4.50.00.00.01.84.20.6
Pulmonx Corporation stock logo
LUNG
Pulmonx
3.104 of 5 stars
3.35.00.00.00.63.30.6
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
1.5753 of 5 stars
2.12.00.00.01.83.30.6
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
3.1531 of 5 stars
3.02.00.00.00.62.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
3.00
Buy$26.8971.16% Upside
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.63
Moderate Buy$11.53243.52% Upside
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2.29
Hold$3.9312.41% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.00
Hold$16.0060.95% Upside

Current Analyst Ratings Breakdown

Latest LUNG, TCMD, SGHT, and LQDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $4.00
6/18/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $4.00
6/12/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$23.00 ➝ $25.00
6/11/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $23.00
6/2/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$36.00 ➝ $37.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $23.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
5/28/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $35.00
5/27/2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/22/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.50 ➝ $4.15
(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
$14M95.93N/AN/A$0.91 per share17.26
Pulmonx Corporation stock logo
LUNG
Pulmonx
$83.79M1.61N/AN/A$2.17 per share1.55
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$79.87M2.26N/AN/A$1.72 per share2.03
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$293.16M0.79$1.13 per share8.80$9.03 per share1.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$130.39M-$1.58N/AN/AN/A-903.80%-177.91%-60.15%8/6/2025 (Estimated)
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$56.39M-$1.44N/AN/AN/A-65.27%-63.69%-34.94%7/30/2025 (Estimated)
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$51.51M-$0.98N/AN/AN/A-63.24%-54.62%-34.92%7/30/2025 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$16.96M$0.6615.0811.83N/A5.52%8.41%6.10%8/4/2025 (Estimated)

Latest LUNG, TCMD, SGHT, and LQDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.25N/AN/AN/A$18.18 millionN/A
8/6/2025Q2 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.43N/AN/AN/A$3.90 millionN/A
8/4/2025Q2 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.09N/AN/AN/A$73.93 millionN/A
7/30/2025Q2 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.40N/AN/AN/A$23.46 millionN/A
5/8/2025Q1 2025
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
-$0.42-$0.45-$0.03-$0.45$3.23 million$3.12 million
5/8/2025Q1 2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.29-$0.28+$0.01-$0.28$16.51 million$17.51 million
5/7/2025Q1 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 million
5/5/2025Q1 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
N/AN/AN/AN/AN/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
2.08
2.93
2.91
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.38
4.97
4.29
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.51
10.47
9.99
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.11
4.52
3.99

Institutional Ownership

CompanyInstitutional Ownership
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
64.54%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
55.51%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
30.10%
Pulmonx Corporation stock logo
LUNG
Pulmonx
6.80%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
28.90%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Liquidia Technologies, Inc. stock logo
LQDA
Liquidia Technologies
5085.49 million59.75 millionOptionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25040.26 million37.52 millionOptionable
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
21051.70 million36.76 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,03723.25 million22.67 millionOptionable

Recent News About These Companies

Tactile Systems stock tumbles after Q1 miss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Liquidia Technologies stock logo

Liquidia Technologies NASDAQ:LQDA

$15.71 +0.61 (+4.04%)
As of 10:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$3.36 +0.18 (+5.50%)
As of 10:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Sight Sciences stock logo

Sight Sciences NASDAQ:SGHT

$3.50 +0.07 (+2.01%)
As of 10:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$9.94 +0.28 (+2.91%)
As of 10:37 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.